Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,900.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 3,200.00
  • 52 Week Low: 1,700.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 6,895
  • Market Cap: £99.27m
  • Beta: 0.22
Select chart: 1 week | 1 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 12.50 9.40 136.10p 14.0 n/a -6% 150.00p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
30-Jun-2026 12 n/a n/a n/a n/a n/a
 
Earnings
30-Jun-2026 136.10p n/a n/a n/a n/a n/a
 
Dividend
30-Jun-2026 150.00p n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 0 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 0 0 0 0 0 0
 
Average Rec n/a n/a n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Bioventix Market Data

Currency UK Pounds
Share Price 1,900.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 3,200.00
52 Week Low 1,700.00
Volume 6,895
Shares Issued 5.22m
Market Cap £99.27m
Beta 0.22

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 06-Nov-25 10-Apr-25
Paid 21-Nov-25 25-Apr-25
Amount 80.00p 70.00p

Trades for 29-Jan-2026

Time Volume / Share Price
16:15 199 @ 1,860.00p
15:57 36 @ 1,855.00p
15:56 23 @ 1,950.00p
15:56 900 @ 1,902.00p
15:52 230 @ 1,950.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page